BRIEF-Health Canada Approves New Indication For Lung Cancer Treatment Option Alunbrig®

Reuters · 03/17/2021 12:32
BRIEF-Health Canada Approves New Indication For Lung Cancer Treatment Option Alunbrig®

- Takeda Pharmaceutical Co Ltd 4502.T:

  • HEALTH CANADA APPROVES NEW INDICATION FOR LUNG CANCER TREATMENT OPTION ALUNBRIG®

  • TAKEDA CANADA INC. - HEALTH CANADA HAS ISSUED ALUNBRIG(BRIGATINIB TABLETS) MARKETING AUTHORIZATION WITHOUT CONDITIONS

Source text for Eikon: ID:nCNWnFXsBa

Further company coverage: 4502.T


((Reuters.Briefs@thomsonreuters.com;))